8 completed. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 8 |
Follow Death, Sudden: new trials by email Literature Review of Death, Sudden trials Research Report on Death, Sudden
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest Coolgard, ArcticSun, Conventional treatment - Cardiac Arrest, Hypothermia | Phase 4 | Completed | University of Leipzig | 120 | 2008-04-01 | 2010-02-02 |
| Survival of Patients With Primary Prophylactic ICD Indication Intensified diagnostic and treatment measures following 1st appropriate ICD therapy, Standard follow-up - Primary Prevention, Tachycardia, Ventricular | Phase 4 | Completed | Biotronik SE & Co. KG | 504 | 2008-02-01 | 2015-01-12 |
| 'Effect of CRT on Defibrillation Threshold Estimates' Study Cardiac Resynchronization Therapy - Defibrillator (CRT-D) - Sudden Cardiac Death | Phase 4 | Completed | Abbott Medical Devices | 77 | 2008-01-01 | 2019-02-05 |
| Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy Idursulfase - Hunter Syndrome, Mucopolysaccharidosis II | Phase 4 | Completed | Shire | 28 | 2007-12-31 | 2021-06-08 |
| Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications Ovatio VR 6250 or DR6550 - Sudden Cardiac Death | Phase 4 | Completed | LivaNova | 198 | 2007-12-01 | 2015-01-12 |
| Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. Retapamulin Ointment, 1% - Skin Infections, Bacterial | Phase 4 | Completed | GlaxoSmithKline | 60 | 2007-09-01 | 2016-12-28 |
| POWER (Pulse Width Optimized Waveform Evaluation Trial) Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT-D) - Sudden Cardiac Death | Phase 4 | Completed | Abbott Medical Devices | 217 | 2006-08-01 | 2019-02-20 |
| Protective Effect of EPA on Cardiovascular Events Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM) - Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease | Phase 4 | Completed | Kobe University | 18000 | 1996-11-01 | 2015-11-20 |
Death, Sudden, Cardiac (6) · Sudden Infant Death (2) · Angina, Unstable (1) · Cellulitis (1) · Coronary Artery Disease (1) · Heart Arrest (1) · Heart Failure (1) · Hypothermia (1) · Impetigo (1) · Infections (1) · Lysosomal Storage Diseases (1) · Mucopolysaccharidosis II (1) · Myocardial Infarction (1) · Neurologic Manifestations (1) · Peripheral Arterial Disease (1)
Death (8) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Cardiovascular Diseases (6) · Heart Diseases (6) · Heart Arrest (5) · Nervous System Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Connective Tissue Diseases (2) · Infant Death (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Skin and Connective Tissue Diseases (2) · Angina Pectoris (1)
Cardiac Resynchronization Therapy (1) · Defibrillators, Implantable (1) · idursulfase (1)
Abbott Medical Devices (2) · Biotronik SE & Co. KG (1) · GlaxoSmithKline (1) · Kobe University (1) · LivaNova (1) · Shire (1) · University of Leipzig (1)
Germany (4) · United States (4) · Poland (2) · Spain (2) · Taiwan (2) · Argentina (1) · Austria (1) · Brazil (1) · Canada (1) · Chile (1) · Costa Rica (1) · Czechia (1) · Hungary (1) · Israel (1) · Japan (1)
Amir Hedayati, MD (1) · Holger Thiele, Associate Professor (1) · Michael Gold, MD, PhD (1) · Mitsuhiro Yokoyama, MD, PhD. (1) · Robert Hatala, Prof. MUDr. (1) · Shephal Doshi, MD (1) · Undine Pittl, MD (1)
PMID 17398308, PMID 18451347, PMID 18667204, PMID 19423946, PMID 19447387, PMID 20145342, PMID 20484828, PMID 21315841, PMID 25902842